期刊文献+

甘糖酯对大鼠肝脏CuZn-SOD mRNA表达和酶活的诱导作用 被引量:2

INDUCTION OF CuZn-SOD mRNA EXPRESSION AND ACTIVITY BY PGMS IN RAT LIVER
暂未订购
导出
摘要 目的 探讨甘糖酯对大鼠肝脏CuZn SOD的诱导作用。方法 RT PCR法检测甘糖酯po后的Wistar大鼠肝脏中CuZn SODmRNA的表达情况 ;亚硝酸盐法测定肝组织中CuZn SOD酶活。结果 po甘糖酯后 ,高剂量组大鼠肝组织的SODmRNA水平与对照组相比有显著的差异 (P <0 0 1) ;高剂量组大鼠肝组织CuZn SOD活力与对照组相比有非常显著的差异 (P <0 0 0 1) ,而中剂量组和低剂量组CuZn SOD活力与对照组相比有显著的差异 (P <0 0 1)。结论 甘糖酯能够诱导大鼠肝组织中CuZn SODmRNA的表达 ,并提高其酶活 。 AIM To study the effect of propylene glycol mannate sulfate (PGMS) on induction of CuZn SOD. METHODS Wistar rats were given PGMS po at different doses (0, 18 9, 37 8 and 75 6 mg·kg -1 ·d) for ten days. Then the rats were sacrificed and the total RNA was extracted from the livers. The total RNA samples were loaded on a 1% agarose gel to detect the quality of total RNA. RT PCR was applied to study the expression of CuZn SOD mRNA in rat livers. The amplified products were detected by the 1 5% agarose gel electrophoresis. Simultaneously, the CuZn SOD activities in rat liver were determined by nitrite method. RESULTS The total RNA extracted from rat livers was integrated without being decomposed by RNase. The level of CuZn SOD mRNA of the high dosage group (75 6 mg·kg -1 ·d) was higher than that of the control group (0 mg·kg -1 ·d) ( P <0 01); the CuZn SOD activities of the high dosage group were significantly higher than those of the control group ( P <0 001) and the CuZn SOD activities of the middle (37 8 mg·kg -1 ·d) and low dosage groups (18 9 mg·kg -1 ·d) were higher than those of the control group ( P <0 01). CONCLUSION PGMS can increase the CuZn SOD activities as well as CuZn SOD on mRNA level. Therefore, it is possible for PGMS to counteract Atherosclerosis (AS) by inducing the expression of CuZn SOD.
出处 《药学学报》 CAS CSCD 北大核心 2002年第1期23-26,共4页 Acta Pharmaceutica Sinica
关键词 甘糖酯 超氧物歧化酶 反转录聚合酶链式反应 mRNA CUZN-SOD 大鼠 propylene glycol mannate sulfate (PGMS) CuZn SOD RT PCR
  • 相关文献

参考文献7

  • 1Chen XM Yuan W.-[J].中国医药工业杂志,1992,23(8):375-375.
  • 2Jiang GH Yuan W.-[J].中国海洋药物杂志,1994,49(1):6-13.
  • 3Zhang AJ Zhou XB.-[J].中国药理学通报,1995,11(4):323-325.
  • 4Han ZY Wang WB.-[J].中国海洋药物杂志,1994,52(4):29-33.
  • 5Hu MW Zhou XB.-[J].药学学报,1995,30(9):641-645.
  • 6Zhang XM Wei XB.-[J].中国海洋药物杂志,1998,68(4):15-17.
  • 7Li YQ Sheng SH.-[J].中国海洋药物杂志,1995,55(3):14-16.

同被引文献25

  • 1陈晓,路新枝,高焱,史晓翀,于文功.甘糖酯抗氧化作用的分子机制[J].药学学报,2004,39(1):13-16. 被引量:9
  • 2陈献明,张瑞雪,袁玮.甘糖酯对鹌鹑肝脏和动脉壁胆固醇及丙二醛含量的影响[J].中国医药工业杂志,1993,24(9):402-404. 被引量:1
  • 3张爱娟,周序斌,张黎华,徐红岩,徐彩珍.甘糖酯抗内皮细胞损伤的研究[J].中国药理学通报,1995,11(4):323-326. 被引量:16
  • 4杨丽霞,张崇德.甘糖酯对人脐静脉内皮细胞过氧化损伤的保护作用[J].中国循环杂志,1995,10(10):617-619. 被引量:6
  • 5Linker A, Jones R S. A new potysaccharide resembling atginic acid isolated from pseudomonads [J]. J Biol Chem, 1966, 241: 384-3851.
  • 6Govan J R W, Fyfe J F M, Jarman T R. Isolation of alginate-producing mutants of Pseudomonas fuorescens, Pseudomonas putida, and Pseudomonas mendocina [J]. J Gen Microbiol, 1981, 25: 217-220.
  • 7Gorin P A, Spencer J F T. Exocellular alginic acid from Azotobacter vinelandii [J]. Can J Chem, 1966, 44:993-998.
  • 8Cote G L, Krull L H. Characterization of the exocellular polysaccharides from Azotobacter chroococcum [J]. Carbohydr Res, 1988, 181: 143-152.
  • 9Chimis C E, Ohman D E. Cloning of Pseudomonas aeruginosa algG, which controls alginate structure [J]. J Bacteriol, 1990, 172: 2894-2900.
  • 10Franklin M J, Ohman D E. Identification of algF in the alginate biosynthetic gene cluster of Pseudomonas aeruginosa which is required for alginate acety-lation [J]. J Bacteriol, 1993, 175: 5057-5065.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部